Global Andrographolide Tablets Market Growth 2026-2032
The global Andrographolide Tablets market size is predicted to grow from US$ 21.29 million in 2025 to US$ 31.15 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.
Andrographolide tablets are a type of medicine whose main effects are used for bacterial dysentery, gastroenteritis, tonsillitis, pharyngitis, bronchitis, etc.
United States market for Andrographolide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Andrographolide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Andrographolide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Andrographolide Tablets players cover Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Wuxi Jiyushanwei Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd., Hainan Huipson Pharmaceutical Biotechnology Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Andrographolide Tablets Industry Forecast? looks at past sales and reviews total world Andrographolide Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Andrographolide Tablets sales for 2026 through 2032. With Andrographolide Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Andrographolide Tablets industry.
This Insight Report provides a comprehensive analysis of the global Andrographolide Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Andrographolide Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Andrographolide Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Andrographolide Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Andrographolide Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Andrographolide Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Andrographolide Tablets market?
What factors are driving Andrographolide Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Andrographolide Tablets market opportunities vary by end market size?
How does Andrographolide Tablets break out by Type, by Application?
Andrographolide tablets are a type of medicine whose main effects are used for bacterial dysentery, gastroenteritis, tonsillitis, pharyngitis, bronchitis, etc.
United States market for Andrographolide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Andrographolide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Andrographolide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Andrographolide Tablets players cover Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Wuxi Jiyushanwei Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd., Hainan Huipson Pharmaceutical Biotechnology Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Andrographolide Tablets Industry Forecast? looks at past sales and reviews total world Andrographolide Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Andrographolide Tablets sales for 2026 through 2032. With Andrographolide Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Andrographolide Tablets industry.
This Insight Report provides a comprehensive analysis of the global Andrographolide Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Andrographolide Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Andrographolide Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Andrographolide Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Andrographolide Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Andrographolide Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Dispersible Tablets
- Conventional Tablets
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
- Henan Furentang Pharmaceutical Co., Ltd.
- Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
- Jiangxi Qingfeng Pharmaceutical Co., Ltd.
- Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
- Guangdong Wannianqing Pharmaceutical Co., Ltd.
- Sinopharm Group Yibin Pharmaceutical Co., Ltd.
- Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
- Hubei Keyi Pharmaceutical Co., Ltd.
What is the 10-year outlook for the global Andrographolide Tablets market?
What factors are driving Andrographolide Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Andrographolide Tablets market opportunities vary by end market size?
How does Andrographolide Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Andrographolide Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Andrographolide Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Andrographolide Tablets by Country/Region, 2021, 2025 & 2032
2.2 Andrographolide Tablets Segment by Type
2.2.1 Dispersible Tablets
2.2.2 Conventional Tablets
2.2.3 Andrographolide Tablets Sales by Type
2.2.3.1 Global Andrographolide Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Andrographolide Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Andrographolide Tablets Sale Price by Type (2021-2026)
2.3 Andrographolide Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Andrographolide Tablets Sales by Application
2.3.4.1 Global Andrographolide Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Andrographolide Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Andrographolide Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Andrographolide Tablets Breakdown Data by Company
3.1.1 Global Andrographolide Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Andrographolide Tablets Sales Market Share by Company (2021-2026)
3.2 Global Andrographolide Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Andrographolide Tablets Revenue by Company (2021-2026)
3.2.2 Global Andrographolide Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Andrographolide Tablets Sale Price by Company
3.4 Key Manufacturers Andrographolide Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Andrographolide Tablets Product Location Distribution
3.4.2 Players Andrographolide Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANDROGRAPHOLIDE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Andrographolide Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Andrographolide Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Andrographolide Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Andrographolide Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Andrographolide Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Andrographolide Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Andrographolide Tablets Sales Growth
4.4 APAC Andrographolide Tablets Sales Growth
4.5 Europe Andrographolide Tablets Sales Growth
4.6 Middle East & Africa Andrographolide Tablets Sales Growth
5 AMERICAS
5.1 Americas Andrographolide Tablets Sales by Country
5.1.1 Americas Andrographolide Tablets Sales by Country (2021-2026)
5.1.2 Americas Andrographolide Tablets Revenue by Country (2021-2026)
5.2 Americas Andrographolide Tablets Sales by Type (2021-2026)
5.3 Americas Andrographolide Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Andrographolide Tablets Sales by Region
6.1.1 APAC Andrographolide Tablets Sales by Region (2021-2026)
6.1.2 APAC Andrographolide Tablets Revenue by Region (2021-2026)
6.2 APAC Andrographolide Tablets Sales by Type (2021-2026)
6.3 APAC Andrographolide Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Andrographolide Tablets by Country
7.1.1 Europe Andrographolide Tablets Sales by Country (2021-2026)
7.1.2 Europe Andrographolide Tablets Revenue by Country (2021-2026)
7.2 Europe Andrographolide Tablets Sales by Type (2021-2026)
7.3 Europe Andrographolide Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Andrographolide Tablets by Country
8.1.1 Middle East & Africa Andrographolide Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Andrographolide Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Andrographolide Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Andrographolide Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Andrographolide Tablets
10.3 Manufacturing Process Analysis of Andrographolide Tablets
10.4 Industry Chain Structure of Andrographolide Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Andrographolide Tablets Distributors
11.3 Andrographolide Tablets Customer
12 WORLD FORECAST REVIEW FOR ANDROGRAPHOLIDE TABLETS BY GEOGRAPHIC REGION
12.1 Global Andrographolide Tablets Market Size Forecast by Region
12.1.1 Global Andrographolide Tablets Forecast by Region (2027-2032)
12.1.2 Global Andrographolide Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Andrographolide Tablets Forecast by Type (2027-2032)
12.7 Global Andrographolide Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
13.1.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
13.1.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.1.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.1.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Latest Developments
13.2 Henan Furentang Pharmaceutical Co., Ltd.
13.2.1 Henan Furentang Pharmaceutical Co., Ltd. Company Information
13.2.2 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.2.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Henan Furentang Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Henan Furentang Pharmaceutical Co., Ltd. Latest Developments
13.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
13.3.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
13.3.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.3.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Latest Developments
13.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
13.4.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
13.4.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.4.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Latest Developments
13.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
13.5.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
13.5.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.5.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Main Business Overview
13.5.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Latest Developments
13.6 Guangdong Wannianqing Pharmaceutical Co., Ltd.
13.6.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
13.6.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.6.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Latest Developments
13.7 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
13.7.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
13.7.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.7.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Latest Developments
13.8 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
13.8.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
13.8.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.8.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Latest Developments
13.9 Hubei Keyi Pharmaceutical Co., Ltd.
13.9.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
13.9.2 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.9.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hubei Keyi Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Hubei Keyi Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Andrographolide Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Andrographolide Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Andrographolide Tablets by Country/Region, 2021, 2025 & 2032
2.2 Andrographolide Tablets Segment by Type
2.2.1 Dispersible Tablets
2.2.2 Conventional Tablets
2.2.3 Andrographolide Tablets Sales by Type
2.2.3.1 Global Andrographolide Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Andrographolide Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Andrographolide Tablets Sale Price by Type (2021-2026)
2.3 Andrographolide Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Andrographolide Tablets Sales by Application
2.3.4.1 Global Andrographolide Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Andrographolide Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Andrographolide Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Andrographolide Tablets Breakdown Data by Company
3.1.1 Global Andrographolide Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Andrographolide Tablets Sales Market Share by Company (2021-2026)
3.2 Global Andrographolide Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Andrographolide Tablets Revenue by Company (2021-2026)
3.2.2 Global Andrographolide Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Andrographolide Tablets Sale Price by Company
3.4 Key Manufacturers Andrographolide Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Andrographolide Tablets Product Location Distribution
3.4.2 Players Andrographolide Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANDROGRAPHOLIDE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Andrographolide Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Andrographolide Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Andrographolide Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Andrographolide Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Andrographolide Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Andrographolide Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Andrographolide Tablets Sales Growth
4.4 APAC Andrographolide Tablets Sales Growth
4.5 Europe Andrographolide Tablets Sales Growth
4.6 Middle East & Africa Andrographolide Tablets Sales Growth
5 AMERICAS
5.1 Americas Andrographolide Tablets Sales by Country
5.1.1 Americas Andrographolide Tablets Sales by Country (2021-2026)
5.1.2 Americas Andrographolide Tablets Revenue by Country (2021-2026)
5.2 Americas Andrographolide Tablets Sales by Type (2021-2026)
5.3 Americas Andrographolide Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Andrographolide Tablets Sales by Region
6.1.1 APAC Andrographolide Tablets Sales by Region (2021-2026)
6.1.2 APAC Andrographolide Tablets Revenue by Region (2021-2026)
6.2 APAC Andrographolide Tablets Sales by Type (2021-2026)
6.3 APAC Andrographolide Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Andrographolide Tablets by Country
7.1.1 Europe Andrographolide Tablets Sales by Country (2021-2026)
7.1.2 Europe Andrographolide Tablets Revenue by Country (2021-2026)
7.2 Europe Andrographolide Tablets Sales by Type (2021-2026)
7.3 Europe Andrographolide Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Andrographolide Tablets by Country
8.1.1 Middle East & Africa Andrographolide Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Andrographolide Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Andrographolide Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Andrographolide Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Andrographolide Tablets
10.3 Manufacturing Process Analysis of Andrographolide Tablets
10.4 Industry Chain Structure of Andrographolide Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Andrographolide Tablets Distributors
11.3 Andrographolide Tablets Customer
12 WORLD FORECAST REVIEW FOR ANDROGRAPHOLIDE TABLETS BY GEOGRAPHIC REGION
12.1 Global Andrographolide Tablets Market Size Forecast by Region
12.1.1 Global Andrographolide Tablets Forecast by Region (2027-2032)
12.1.2 Global Andrographolide Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Andrographolide Tablets Forecast by Type (2027-2032)
12.7 Global Andrographolide Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
13.1.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
13.1.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.1.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.1.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Latest Developments
13.2 Henan Furentang Pharmaceutical Co., Ltd.
13.2.1 Henan Furentang Pharmaceutical Co., Ltd. Company Information
13.2.2 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.2.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Henan Furentang Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Henan Furentang Pharmaceutical Co., Ltd. Latest Developments
13.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
13.3.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
13.3.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.3.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Latest Developments
13.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
13.4.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
13.4.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.4.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Latest Developments
13.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
13.5.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
13.5.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.5.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Main Business Overview
13.5.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Latest Developments
13.6 Guangdong Wannianqing Pharmaceutical Co., Ltd.
13.6.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
13.6.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.6.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Latest Developments
13.7 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
13.7.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
13.7.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.7.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Latest Developments
13.8 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
13.8.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
13.8.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.8.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Latest Developments
13.9 Hubei Keyi Pharmaceutical Co., Ltd.
13.9.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
13.9.2 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolios and Specifications
13.9.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hubei Keyi Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Hubei Keyi Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AndrographolideTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. AndrographolideTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DispersibleTablets
Table 4. Major Players of ConventionalTablets
Table 5. Global AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global AndrographolideTablets Sales Market Share by Type (2021-2026)
Table 7. Global AndrographolideTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global AndrographolideTablets Revenue Market Share by Type (2021-2026)
Table 9. Global AndrographolideTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global AndrographolideTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global AndrographolideTablets Sale Market Share by Application (2021-2026)
Table 12. Global AndrographolideTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global AndrographolideTablets Revenue Market Share by Application (2021-2026)
Table 14. Global AndrographolideTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global AndrographolideTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global AndrographolideTablets Sales Market Share by Company (2021-2026)
Table 17. Global AndrographolideTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global AndrographolideTablets Revenue Market Share by Company (2021-2026)
Table 19. Global AndrographolideTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers AndrographolideTablets Producing Area Distribution and Sales Area
Table 21. Players AndrographolideTablets Products Offered
Table 22. AndrographolideTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global AndrographolideTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global AndrographolideTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global AndrographolideTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global AndrographolideTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global AndrographolideTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global AndrographolideTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global AndrographolideTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global AndrographolideTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas AndrographolideTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas AndrographolideTablets Sales Market Share by Country (2021-2026)
Table 35. Americas AndrographolideTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas AndrographolideTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC AndrographolideTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC AndrographolideTablets Sales Market Share by Region (2021-2026)
Table 40. APAC AndrographolideTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC AndrographolideTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe AndrographolideTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe AndrographolideTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe AndrographolideTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa AndrographolideTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa AndrographolideTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa AndrographolideTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of AndrographolideTablets
Table 52. Key Market Challenges & Risks of AndrographolideTablets
Table 53. Key Industry Trends of AndrographolideTablets
Table 54. AndrographolideTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. AndrographolideTablets Distributors List
Table 57. AndrographolideTablets Customer List
Table 58. Global AndrographolideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global AndrographolideTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas AndrographolideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas AndrographolideTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC AndrographolideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC AndrographolideTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe AndrographolideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe AndrographolideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa AndrographolideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa AndrographolideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global AndrographolideTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global AndrographolideTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global AndrographolideTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global AndrographolideTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 74. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Main Business
Table 76. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 77. Henan Furentang Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Henan Furentang Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 79. Henan Furentang Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Henan Furentang Pharmaceutical Co., Ltd. Main Business
Table 81. Henan Furentang Pharmaceutical Co., Ltd. Latest Developments
Table 82. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 84. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Main Business
Table 86. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Latest Developments
Table 87. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Jiangxi Qingfeng Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 89. Jiangxi Qingfeng Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Main Business
Table 91. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Latest Developments
Table 92. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 94. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Main Business
Table 96. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Latest Developments
Table 97. Guangdong Wannianqing Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Guangdong Wannianqing Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 99. Guangdong Wannianqing Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Guangdong Wannianqing Pharmaceutical Co., Ltd. Main Business
Table 101. Guangdong Wannianqing Pharmaceutical Co., Ltd. Latest Developments
Table 102. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Sinopharm Group Yibin Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 104. Sinopharm Group Yibin Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Main Business
Table 106. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Latest Developments
Table 107. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 109. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Main Business
Table 111. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Latest Developments
Table 112. Hubei Keyi Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Hubei Keyi Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 114. Hubei Keyi Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Hubei Keyi Pharmaceutical Co., Ltd. Main Business
Table 116. Hubei Keyi Pharmaceutical Co., Ltd. Latest Developments
Table 1. AndrographolideTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. AndrographolideTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DispersibleTablets
Table 4. Major Players of ConventionalTablets
Table 5. Global AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global AndrographolideTablets Sales Market Share by Type (2021-2026)
Table 7. Global AndrographolideTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global AndrographolideTablets Revenue Market Share by Type (2021-2026)
Table 9. Global AndrographolideTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global AndrographolideTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global AndrographolideTablets Sale Market Share by Application (2021-2026)
Table 12. Global AndrographolideTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global AndrographolideTablets Revenue Market Share by Application (2021-2026)
Table 14. Global AndrographolideTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global AndrographolideTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global AndrographolideTablets Sales Market Share by Company (2021-2026)
Table 17. Global AndrographolideTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global AndrographolideTablets Revenue Market Share by Company (2021-2026)
Table 19. Global AndrographolideTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers AndrographolideTablets Producing Area Distribution and Sales Area
Table 21. Players AndrographolideTablets Products Offered
Table 22. AndrographolideTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global AndrographolideTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global AndrographolideTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global AndrographolideTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global AndrographolideTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global AndrographolideTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global AndrographolideTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global AndrographolideTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global AndrographolideTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas AndrographolideTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas AndrographolideTablets Sales Market Share by Country (2021-2026)
Table 35. Americas AndrographolideTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas AndrographolideTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC AndrographolideTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC AndrographolideTablets Sales Market Share by Region (2021-2026)
Table 40. APAC AndrographolideTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC AndrographolideTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe AndrographolideTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe AndrographolideTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe AndrographolideTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa AndrographolideTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa AndrographolideTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa AndrographolideTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa AndrographolideTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of AndrographolideTablets
Table 52. Key Market Challenges & Risks of AndrographolideTablets
Table 53. Key Industry Trends of AndrographolideTablets
Table 54. AndrographolideTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. AndrographolideTablets Distributors List
Table 57. AndrographolideTablets Customer List
Table 58. Global AndrographolideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global AndrographolideTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas AndrographolideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas AndrographolideTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC AndrographolideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC AndrographolideTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe AndrographolideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe AndrographolideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa AndrographolideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa AndrographolideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global AndrographolideTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global AndrographolideTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global AndrographolideTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global AndrographolideTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 74. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Main Business
Table 76. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 77. Henan Furentang Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Henan Furentang Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 79. Henan Furentang Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Henan Furentang Pharmaceutical Co., Ltd. Main Business
Table 81. Henan Furentang Pharmaceutical Co., Ltd. Latest Developments
Table 82. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 84. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Main Business
Table 86. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Latest Developments
Table 87. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Jiangxi Qingfeng Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 89. Jiangxi Qingfeng Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Main Business
Table 91. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Latest Developments
Table 92. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 94. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Main Business
Table 96. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Latest Developments
Table 97. Guangdong Wannianqing Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Guangdong Wannianqing Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 99. Guangdong Wannianqing Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Guangdong Wannianqing Pharmaceutical Co., Ltd. Main Business
Table 101. Guangdong Wannianqing Pharmaceutical Co., Ltd. Latest Developments
Table 102. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Sinopharm Group Yibin Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 104. Sinopharm Group Yibin Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Main Business
Table 106. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Latest Developments
Table 107. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 109. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Main Business
Table 111. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Latest Developments
Table 112. Hubei Keyi Pharmaceutical Co., Ltd. Basic Information, AndrographolideTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Hubei Keyi Pharmaceutical Co., Ltd. AndrographolideTablets Product Portfolios and Specifications
Table 114. Hubei Keyi Pharmaceutical Co., Ltd. AndrographolideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Hubei Keyi Pharmaceutical Co., Ltd. Main Business
Table 116. Hubei Keyi Pharmaceutical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of AndrographolideTablets
Figure 2. AndrographolideTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global AndrographolideTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global AndrographolideTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. AndrographolideTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. AndrographolideTablets Sales Market Share by Country/Region (2025)
Figure 10. AndrographolideTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of DispersibleTablets
Figure 12. Product Picture of ConventionalTablets
Figure 13. Global AndrographolideTablets Sales Market Share by Type in 2026
Figure 14. Global AndrographolideTablets Revenue Market Share by Type (2021-2026)
Figure 15. AndrographolideTablets Consumed in Hospital
Figure 16. Global AndrographolideTablets Market: Hospital (2021-2026) & (K Units)
Figure 17. AndrographolideTablets Consumed in Clinic
Figure 18. Global AndrographolideTablets Market: Clinic (2021-2026) & (K Units)
Figure 19. AndrographolideTablets Consumed in Other
Figure 20. Global AndrographolideTablets Market: Other (2021-2026) & (K Units)
Figure 21. Global AndrographolideTablets Sale Market Share by Application (2025)
Figure 22. Global AndrographolideTablets Revenue Market Share by Application in 2026
Figure 23. AndrographolideTablets Sales by Company in 2026 (K Units)
Figure 24. Global AndrographolideTablets Sales Market Share by Company in 2026
Figure 25. AndrographolideTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global AndrographolideTablets Revenue Market Share by Company in 2026
Figure 27. Global AndrographolideTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global AndrographolideTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas AndrographolideTablets Sales 2021-2026 (K Units)
Figure 30. Americas AndrographolideTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC AndrographolideTablets Sales 2021-2026 (K Units)
Figure 32. APAC AndrographolideTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe AndrographolideTablets Sales 2021-2026 (K Units)
Figure 34. Europe AndrographolideTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa AndrographolideTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa AndrographolideTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas AndrographolideTablets Sales Market Share by Country in 2026
Figure 38. Americas AndrographolideTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas AndrographolideTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas AndrographolideTablets Sales Market Share by Application (2021-2026)
Figure 41. United States AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC AndrographolideTablets Sales Market Share by Region in 2026
Figure 46. APAC AndrographolideTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC AndrographolideTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC AndrographolideTablets Sales Market Share by Application (2021-2026)
Figure 49. China AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe AndrographolideTablets Sales Market Share by Country in 2026
Figure 57. Europe AndrographolideTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe AndrographolideTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe AndrographolideTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa AndrographolideTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa AndrographolideTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa AndrographolideTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of AndrographolideTablets in 2026
Figure 74. Manufacturing Process Analysis of AndrographolideTablets
Figure 75. Industry Chain Structure of AndrographolideTablets
Figure 76. Channels of Distribution
Figure 77. Global AndrographolideTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global AndrographolideTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global AndrographolideTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global AndrographolideTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global AndrographolideTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global AndrographolideTablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of AndrographolideTablets
Figure 2. AndrographolideTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global AndrographolideTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global AndrographolideTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. AndrographolideTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. AndrographolideTablets Sales Market Share by Country/Region (2025)
Figure 10. AndrographolideTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of DispersibleTablets
Figure 12. Product Picture of ConventionalTablets
Figure 13. Global AndrographolideTablets Sales Market Share by Type in 2026
Figure 14. Global AndrographolideTablets Revenue Market Share by Type (2021-2026)
Figure 15. AndrographolideTablets Consumed in Hospital
Figure 16. Global AndrographolideTablets Market: Hospital (2021-2026) & (K Units)
Figure 17. AndrographolideTablets Consumed in Clinic
Figure 18. Global AndrographolideTablets Market: Clinic (2021-2026) & (K Units)
Figure 19. AndrographolideTablets Consumed in Other
Figure 20. Global AndrographolideTablets Market: Other (2021-2026) & (K Units)
Figure 21. Global AndrographolideTablets Sale Market Share by Application (2025)
Figure 22. Global AndrographolideTablets Revenue Market Share by Application in 2026
Figure 23. AndrographolideTablets Sales by Company in 2026 (K Units)
Figure 24. Global AndrographolideTablets Sales Market Share by Company in 2026
Figure 25. AndrographolideTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global AndrographolideTablets Revenue Market Share by Company in 2026
Figure 27. Global AndrographolideTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global AndrographolideTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas AndrographolideTablets Sales 2021-2026 (K Units)
Figure 30. Americas AndrographolideTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC AndrographolideTablets Sales 2021-2026 (K Units)
Figure 32. APAC AndrographolideTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe AndrographolideTablets Sales 2021-2026 (K Units)
Figure 34. Europe AndrographolideTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa AndrographolideTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa AndrographolideTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas AndrographolideTablets Sales Market Share by Country in 2026
Figure 38. Americas AndrographolideTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas AndrographolideTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas AndrographolideTablets Sales Market Share by Application (2021-2026)
Figure 41. United States AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC AndrographolideTablets Sales Market Share by Region in 2026
Figure 46. APAC AndrographolideTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC AndrographolideTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC AndrographolideTablets Sales Market Share by Application (2021-2026)
Figure 49. China AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe AndrographolideTablets Sales Market Share by Country in 2026
Figure 57. Europe AndrographolideTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe AndrographolideTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe AndrographolideTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa AndrographolideTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa AndrographolideTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa AndrographolideTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries AndrographolideTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of AndrographolideTablets in 2026
Figure 74. Manufacturing Process Analysis of AndrographolideTablets
Figure 75. Industry Chain Structure of AndrographolideTablets
Figure 76. Channels of Distribution
Figure 77. Global AndrographolideTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global AndrographolideTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global AndrographolideTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global AndrographolideTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global AndrographolideTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global AndrographolideTablets Revenue Market Share Forecast by Application (2027-2032)